| Literature DB >> 34760662 |
James Dargin1, Susan Stempek1, Yuxiu Lei1, Anthony Gray1, Timothy Liesching1.
Abstract
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, our hospital experienced a large influx of critically ill patients with acute respiratory failure. In order to increase intensive care unit (ICU) surge capacity, we adopted a "tiered model" for ICU provider staffing where multiple ICUs were staffed by noncritical care providers under the direction of an intensivist. We hypothesized that ICUs staffed with a tiered model would result in similar patient outcomes as ICU staffed with a traditional intensivist model.Entities:
Keywords: COVID-19; intensive care units; personnel staffing and scheduling
Year: 2021 PMID: 34760662 PMCID: PMC8547674 DOI: 10.4103/ijciis.ijciis_37_21
Source DB: PubMed Journal: Int J Crit Illn Inj Sci ISSN: 2229-5151
Intensive care unit staffing model used at baseline compared to the staffing model used during the peak of the COVID-19 pandemic
| Unit name | Number of beds | Day staffing | Night staffing* | ||
|---|---|---|---|---|---|
| Baseline staffing | |||||
| SICU | 24 | 2 intensivists (anesthesia or surgery background), 3-4 surgical residents, 1 CT ICU APP | 1-2 surgical residents | ||
| MICU | 12 | 1 intensivist (internal medicine background), 2 critical care APPs | 1 critical care APP | ||
| Mixed MICU/CCU | 16 | 1 intensivist, 1 cardiologist, 4-6 internal medicine residents, 1 PCCM fellow | 2 internal medicine residents | ||
| Pandemic staffing | |||||
| Mixed MICU/CCU† | 16 | 1 noncritical care trained cardiologist, 1 PCCM fellow, 4-6 internal medicine residents, 1 PCCM regional intensivist | 2 noncritical care support staff | ||
| SICU B† | 12 | 1 noncritical care trained anesthesiologist, 1 critical care APP, 1-2 noncritical care support staff, 1 PCCM regional intensivist | 2 noncritical care support staff | ||
| SICU A‡ | 12 | 1 PCCM intensivist, 1 critical care APP, 1-2 noncritical care support staff | 2 noncritical care support staff | ||
| MICU‡ | 12 | 1 neurocritical care intensivist, 1 critical care APP, 1-2 noncritical care support staff | 1 neurocritical care APP and 1 noncritical care support staff | ||
| Inpatient ward #1 converted into ICU‡ | 6 | 1 anesthesia intensivist, 1 noncritical care support staff, 1 critical care APP | 1 noncritical care support staff | ||
| Inpatient ward #2 converted into ICU‡ | 9 | 1 anesthesia intensivist, 1-2 noncritical care support staff, 1 critical care APP | 1 noncritical care support staff | ||
| PACU converted into ICU‡ | 29 | 1 surgical intensivist, 2-4 noncritical care support staff | 1-2 noncritical care support staff |
*Intensivist night coverage at baseline is provided by 1 in-house PCCM intensivist covering all ICUs and 1 anesthesia intensivist providing additional home call for SICU patients. Intensivist coverage for pandemic staffing was provided by 1 in-house PCCM intensivist and 1 in-house anesthesia or neurocritical care intensivist for all ICUs, †Nontraditional “tiered” staffing model used in this ICU, ‡Traditional staffing model used in this ICU. SICU: Surgical intensive care unit, MICU: Medical intensive care unit, CCU: Coronary care unit, PACU: Postanesthesia care unit, PCCM: Pulmonary and critical care medicine, APP: Advanced practice provider, ICU: Intensive care unit, CT: Computed tomography
Characteristics of patients treated in intensive care unit with traditional staffing models versus nontraditional staffing models
| Variable | Total ICU patients ( | Traditional ICU patients ( | Nontraditional ICU patients ( |
|
|---|---|---|---|---|
| Age (mean years±SDa) | 67.3±12.1 | 67.8±11.2 | 66.5±13.1 | 0.55b |
| Race | ||||
| Caucasian | 86 (72.9) | 51 (77.3) | 35 (67.3) | 0.40c |
| African American | 12 (10.2) | 7 (10.6) | 5 (9.6) | |
| Hispanic | 16 (13.6) | 6 (9.1) | 10 (19.2) | |
| Asian | 3 (2.5) | 1 (1.5) | 2 (3.9) | |
| Native American | 1 (0.8) | 1 (1.5) | 0 | |
| Gender, male | 74 (62.7) | 40 (60.6) | 34 (65.4) | 0.70d |
| BMI (mean±SDa) | 31.7±9.3 | 33.1±10.8 | 29.9±6.7 | 0.05b |
| Charlson Comorbidity Index (mean±SDa) | 4.2±2.2 | 4.3±2.2 | 4.1±2.2 | 0.54b |
| Comorbidities | ||||
| CKD | 26 (22) | 13 (19.7) | 13 (25) | 0.51d |
| Hypertension | 81 (68.6) | 46 (69.7) | 35 (67.3) | 0.84d |
| Diabetes mellitus | 51 (43.2) | 29 (43.9) | 22 (42.3) | 1.00d |
| CAD | 19 (16.1) | 12 (18.2) | 7 (13.5) | 0.62d |
| CHF | 10 (8.5) | 6 (9.1) | 4 (7.7) | 1.00d |
| Cirrhosis | 1 (0.9) | 0 | 1 (1.9) | 0.45d |
| Cancer | 14 (11.9) | 10 (15.2) | 4 (7.7) | 0.26d |
| COPD | 16 (13.6) | 9 (13.6) | 7 (13.5) | 1.00d |
| Asthma | 6 (5.1) | 5 (7.6) | 1 (1.9) | 0.23d |
| Dementia | 16 (13.6) | 9 (13.6) | 7 (13.5) | 1.00d |
| SOFA (mean±SDa) | 7.5±2.9 | 7.4±2.9 | 7.7±3 | 0.61b |
| Admission source | ||||
| Home | 33 (28) | 22 (33.3) | 11 (21.2) | 0.26c |
| Nursing home | 26 (22) | 15 (22.7) | 11 (21.2) | |
| Outside hospital transfer | 59 (50) | 29 (43.9) | 30 (57.6) | |
| Initial PaO2/FiO2 (mean±SDa) | 152.2±65.3 | 153.2±67.5 | 150.9±63.0 | 0.85b |
| High flow nasal cannula prior to intubation | 31 (26.3) | 15 (22.7) | 16 (30.8) | 0.40d |
| Noninvasive ventilation prior to intubation | 2 (1.7) | 1 (1.5) | 1 (1.9) | 1.00d |
| Time spent on>6 L/min of oxygen prior to intubation (h), median (IQRe) | 7 (2-25) | 7.5 (2-28) | 7 (2-23) | 0.90f |
| Laboratory studies, median (IQRe) | ||||
| Ferritin (ng/ml) | 1.811 (1.019-3.127) | 1.798 (987-3.900) | 1.811 (1.090-2.903) | 0.91f |
| D-dimer (ng/ml) | 2.000 (786-2.000) | 1.914 (705-2.000) | 2.000 (906-2.000) | 0.23f |
| LDH (U/L) | 566 (425-766) | 566 (428-794) | 560 (421-687) | 0.60f |
| IL-6 (pg/ml) | 26 (7-82) | 45 (10-99) | 19 (7-153) | 0.41f |
| COVID-19 specific treatments | ||||
| Convalescent plasma | 9 (7.6) | 2 (3) | 7 (13.5) | 0.04d |
| Corticosteroids | 79 (67) | 40 (60.6) | 39 (75) | 0.12d |
| Tocilizumab | 25 (21) | 12 (18.2) | 13 (25) | 0.38 |
aSD, bStudent’s t-test, cChi-square test, dFisher’s exact test, eIQR, fSigned rank Wilcoxon test. IQR: Interquartile range, SD: Standard deviation, ICU: Intensive care unit, BMI: Body mass index, CKD: Chronic kidney disease, CAD: Coronary artery disease, CHF: Congestive heart failure, COPD: Chronic obstructive pulmonary disease, LDH: Lactate dehydrogenase, IL-6: Interleukin 6, SOFA: Sequential organ failure assessment, COVID-19: Coronavirus disease 2019
Acute respiratory distress syndrome management strategies and patient outcomes in intensive care unit with traditional staffing models versus nontraditional staffing models
| Variable | Total patients ( | Traditional ICU patients ( | Nontraditional ICU patients ( |
|
|---|---|---|---|---|
| Daily tidal volume (mL/kg IBW), median (IQRa) | 6.2 (5.9-6.6) | 6.2 (5.9-6.7) | 6.2 (5.9-6.6) | 0.95b |
| Daily fluid balance (mL), median (IQRa) | 119 (−341-666) | 159 (−307-681) | 92 (−365-652) | 0.54b |
| Cumulative fluid balance (mL) for ICU stay, median (IQRa) | 492 (−1274-2538) | 635 (−1130-2695) | 235 (−1786-2293) | 0.31b |
| Prone ventilation | 72 (61) | 38 (57.6) | 34 (65.4) | 0.45d |
| Inhaled pulmonary vasodilator therapy | 15 (12.7) | 11 (16.7) | 4 (7.7) | 0.17d |
| Inpatient mortality | 55 (46.6) | 33 (50) | 22 (42.3) | 0.46e |
| Ventilator days, mean±SDa | 15±9.4 | 14.3±9.2 | 15.8±9.7 | 0.40b |
| Ventilator-free days, median (IQRd) | 0 (0-11) | 0 (0-10) | 0 (0-15) | 0.45d |
| ICU LOS, mean±SDa | 15.7±9.3 | 14.8±9.3 | 16.9±9.3 | 0.24b |
| ICU-free days, median (IQRc) | 0 (0-10) | 0 (0-9) | 0 (0-11) | 0.35d |
| Vasopressor days, median (IQRc) | 8 (3-16) | 8 (3-15) | 10 (3-17) | 0.48d |
| Vasopressor-free days, median (IQRc) | 7.5 (0-20) | 4.5 (0-19) | 11 (0-22) | 0.24d |
| Dialysis days, median (IQRc) | 0 (0-2) | 0 (0-2) | 0 (0-4.5) | 0.86d |
| Dialysis-free days, median (IQRc) | 20 (3-28) | 17.5 (3-28) | 28 (2.5-28) | 0.49d |
| Successfully extubated | 45 (38.1) | 24 (36.4) | 21 (40.4) | 0.71e |
| Disposition | ||||
| Discharged home | 10 (8.5) | 5 (7.6) | 5 (9.6) | 0.85f |
| Skilled nursing facility | 14 (11.9) | 7 (10.6) | 7 (13.5) | |
| Died | 55 (46.6) | 33 (50) | 22 (42.3) | |
| Still in hospital | 39 (33.0) | 21 (31.8) | 18 (34.6) |
aSD, bStudent’s t-test, cIQR, dSigned rank Wilcoxon test. eFisher’s exact test, fChi-square test. LOS: Length of stay, IQR: Interquartile range, SD: Standard deviation, ICU: Intensive care unit